Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors
NCT05922358
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER_GOV
Sponsor class
Conditions
Gastrointestinal Tumors
Interventions
COMBINATION_PRODUCT:
Anti-allergic treatment
Sponsor
Fujian Cancer Hospital